Evaluation of the Bioavailability of Pramlintide
| Status: | Completed |
|---|---|
| Conditions: | Diabetes, Diabetes, Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - 70 |
| Updated: | 4/21/2016 |
| Start Date: | June 2002 |
| End Date: | December 2002 |
This is a randomized, open-label, crossover study to examine the bioavailability of
pramlintide in normal weight and overweight subjects with type 1 and type 2 diabetes
mellitus using insulin.
pramlintide in normal weight and overweight subjects with type 1 and type 2 diabetes
mellitus using insulin.
Inclusion Criteria:
- HbA1c value between 6-12%
- BMI <= 27 kg/m2 or BMI >=30 to <= 45 kg/m2
- Consistent insulin regimen for 2 months prior to screening
We found this trial at
4
sites
Click here to add this to my saved trials
5055 South Orange Ave Orlando FL 32909
Orlando, Florida 32806
Orlando, Florida 32806
407-240-7878
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials